Stay updated on Pembrolizumab+Capecitabine+Bevacizumab in MSS Colorectal Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Capecitabine+Bevacizumab in MSS Colorectal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Capecitabine+Bevacizumab in MSS Colorectal Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The study page now indicates that recruitment has ended, clarifying participant eligibility. The page also adds new navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) and standardizes the Intervention/Treatment heading, with a site revision tag updated to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-12T13:42:17.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The page displays a new revision tag, changing from v3.5.4 to v3.5.5, indicating a minor CMS/template update. The change does not alter any study details, eligibility criteria, results, or navigational content.
    Difference
    0.0%
    Check dated 2026-06-05T09:18:47.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    Revision: v3.5.4 was added, replacing the previous v3.5.3. This indicates a small update to the page metadata rather than a change to its substantive content.
    Difference
    0.0%
    Check dated 2026-05-15T05:15:42.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    The page revision updated from v3.5.2 to v3.5.3, indicating a small version update to the study record page. The update does not alter the study details shown to users.
    Difference
    0.0%
    Check dated 2026-04-30T17:55:03.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Revision: v3.5.2 was added and revision: v3.5.0 was removed.
    Difference
    0.0%
    Check dated 2026-04-16T11:16:12.000Z thumbnail image
  7. Check
    94 days ago
    Change Detected
    Summary
    Added a Publications entry for the Phase II study article: Phase II Study of Pembrolizumab Plus Capecitabine and Bevacizumab for Microsatellite Stable/Mismatch Repair-Proficient Metastatic Colorectal Cancer with Clin Colorectal Cancer citation and DOI. The entry is automatically populated from PubMed.
    Difference
    0.3%
    Check dated 2026-03-18T19:34:35.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Capecitabine+Bevacizumab in MSS Colorectal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Capecitabine+Bevacizumab in MSS Colorectal Cancer Clinical Trial page.